Swedish Orphan Biovitrum AB/ SE0000872095 /
6/2/2023 4:36:08 PM | Chg. +2.30 | Volume | Bid4:36:08 PM | Ask4:36:08 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
214.40SEK | +1.08% | 113,714 Turnover: 8.53 mill. |
214.40Bid Size: 467 | 214.60Ask Size: 345 | 63.23 bill.SEK | 0.00% | 19.49 |
Assets
|
2016 IFRS in mill. SEK |
2017 IFRS in mill. SEK |
2018 IFRS in mill. SEK |
2019 IFRS in mill. SEK |
2020 IFRS in mill. SEK |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 121 | 134.2000 | 136.3000 | 518 | 534 | ||||||
Intangible Assets | 6,806 | 6,445.1000 | 10,158.7000 | 37,412 | 38,791 | ||||||
Long-Term Investments | 2 | 35.2000 | 55.4000 | 50 | 179 | ||||||
Fixed Assets | - | - | - | - | - | ||||||
Inventories | 870 | 1,053.3000 | 1,284.1000 | 1,772 | 3,053 | ||||||
Accounts Receivable | 768.8000 | 1,129 | 1,665.2000 | 3,736 | 3,756 | ||||||
Cash and Cash Equivalents | 785.8000 | 1,478.5000 | 2,998.7000 | 737 | 404 | ||||||
Current Assets | 2,911.3000 | 4,157.1000 | 6,601.9000 | 7,323 | 8,168 | ||||||
Total Assets | 9,974.1000 | 10,902.9000 | 17,183.2000 | 45,658 | 48,283 |
Liabilities
|
2016 IFRS in mill. SEK |
2017 IFRS in mill. SEK |
2018 IFRS in mill. SEK |
2019 IFRS in mill. SEK |
2020 IFRS in mill. SEK |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 280.2000 | 358.4000 | 487 | 681 | 569 | ||||||
Long-term debt | - | - | - | 16,141 | 10,137 | ||||||
Liabilities to Banks | 0.0000 | 0.0000 | 0.0000 | 16,141 | 10,137 | ||||||
Provisions | 1,375.7000 | 2,110 | 2,766.1000 | 7,225 | 8,162 | ||||||
Liabilities | 4,619.9000 | 4,202.4000 | 8,143.1000 | 28,728 | 28,077 | ||||||
Share Capital | 149.2540 | 149.5270 | 149.9740 | 165 | 167 | ||||||
Total Equity | 5,354.3000 | 6,700.5000 | 9,040.1000 | 16,930 | 20,206 | ||||||
Minority Interests | - | - | - | - | - | ||||||
Total liabilities equity | 9,974.1000 | 10,902.9000 | 17,183.2000 | 45,658 | 48,283 |
Income Statement
|
2016 IFRS in mill. SEK |
2017 IFRS in mill. SEK |
2018 IFRS in mill. SEK |
2019 IFRS in mill. SEK |
2020 IFRS in mill. SEK |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 5,204.3000 | 6,510.8000 | 9,138.9000 | 14,248 | 15,261 | ||||||
Depreciation (total) | - | - | - | - | - | ||||||
Operating Result | 1,133.1000 | 1,600.4000 | 3,122 | 4,533 | 4,818 | ||||||
Interest Income | -85.2000 | -68 | -40.3000 | -286 | -601 | ||||||
Income Before Taxes | 1,048 | 1,532.4000 | 3,081.7000 | 4,247 | 4,217 | ||||||
Income Taxes | 238.9000 | 383.8000 | 663.9000 | 942 | 972 | ||||||
Minority Interests Profit | - | - | - | - | - | ||||||
Net Income | 809.1000 | 1,148.6000 | 2,417.8000 | 3,304 | 3,245 |
Per Share
Cash Flow
|
2016 IFRS in mill. SEK |
2017 IFRS in mill. SEK |
2018 IFRS in mill. SEK |
2019 IFRS in mill. SEK |
2020 IFRS in mill. SEK |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 342.9000 | 1,332.9000 | 2,090.3000 | 3,634 | 5,214 | ||||||
Cash Flow from Investing Activities | -158 | -139 | -575.5000 | -21,685 | -3,964 | ||||||
Cash Flow from Financing | -307.6000 | -500 | -2.1000 | 15,780 | -1,570 | ||||||
Decrease / Increase in Cash | -122.7000 | 694 | 1,512.9000 | -2,271 | -320 | ||||||
Employees | 760 | 800 | 902 | 1,335 | 1,509 |